SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-009885
Filing Date
2022-01-14
Accepted
2022-01-14 16:19:06
Documents
15
Period of Report
2022-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d656440d8k.htm   iXBRL 8-K 28342
2 EX-1.1 d656440dex11.htm EX-1.1 165647
3 EX-5.1 d656440dex51.htm EX-5.1 7157
7 GRAPHIC g656440g0113195603794.jpg GRAPHIC 2196
  Complete submission text file 0001193125-22-009885.txt   378547

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220114.xsd EX-101.SCH 2915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220114_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220114_pre.xml EX-101.PRE 11423
9 EXTRACTED XBRL INSTANCE DOCUMENT d656440d8k_htm.xml XML 3395
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

IRS No.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 22532087
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences